Title |
Include |
Exclude |
Explanation for Exclusion |
Kishore K, Hariprasad SM, Mungee S. Perioperative Antiplatelet Agents and Anticoagulants in Vitreoretinal Surgery. Ophthalmic Surg Lasers Imaging Retina. 2022 Feb;53(2):71-78. doi: 10.3928/23258160-20220128-01. Epub 2022 Feb 1. PMID: 35148217. |
|
It is not a properly powered clinical study |
Small case series |
Guise PA, Wang K. Haemorrhagic complications following cataract and vitreoretinal surgery with sub-Tenon’s block in patients receiving non-vitamin K oral anticoagulant agents: A prospective audit. Anaesth Intensive Care. 2022 Jul;50(4):289-294. doi: 10.1177/0310057X211057136. Epub 2022 Jan 25. PMID: 35078342. |
|
|
|
Starr MR, Ammar MJ, Patel LG, Boucher N, Yonekawa Y, Garg SJ, Hsu J, Ho AC, Regillo CD, Chiang A. Comparative Incidence of Postoperative Hemorrhage in Vitreoretinal Surgery in Patients on Anti-Coagulants. Ophthalmic Surg Lasers Imaging Retina. 2021 Jul;52(7):374-379. doi: 10.3928/23258160-20210628-03. Epub 2021 Jul 1. PMID: 34309424. |
|
|
|
Lauermann P, Klingelhöfer A, Mielke D, van Oterendorp C, Hoerauf H, Striebe NA, Storch MW, Pfeiffer S, Koscielny J, Sucker C, Bemme S, Feltgen N. Risk Factors for Severe Bleeding Complications in Vitreoretinal Surgery and the Role of Antiplatelet or Anticoagulant Agents. Ophthalmol Retina. 2021 Aug;5(8):e23-e29. doi: 10.1016/j.oret.2021.04.013. Epub 2021 Apr 26. PMID: 33915331. |
|
|
|
Louison S, Gabrielle PH, Soudry A, Meillon C, Blanc J, Béal G, Arsène S, Le Mer Y, Berrod JP, Kodjikian L, Creuzot-Garcher C; CFCR Research net. Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study. Acta Ophthalmol. 2020 Dec;98(8):e991-e997. doi: 10.1111/aos.14434. Epub 2020 Apr 12. PMID: 32279459. |
|
|
|
Bemme S, Lauermann P, Striebe NA, Khattab MH, Affeldt J, Callizo J, Bertelmann T, Pfeiffer S, Hoerauf H, Feltgen N. Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study. Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):961-969. doi: 10.1007/s00417-019-04554-1. Epub 2020 Jan 7. PMID: 31907644. |
|
|
|
Andonegui J, Capdevila F, Zubicoa A, Ibáñez B. Randomised controlled trial on vitreoretinal surgery with and without oral anticoagulants: surgical complications, visual results and perioperative thromboembolic events. Trials. 2019 Dec 4;20(1):677. doi: 10.1186/s13063-019-3805-6. PMID: 31801597; PMCID: PMC6894279. |
|
|
|
Meillon C, Gabrielle PH, Luu M, Aho-Glele LS, Bron AM, Creuzot-Garcher C; CFSR research net. Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):461-467. doi: 10.1007/s00417-017-3897-1. Epub 2018 Jan 23. PMID: 29362869. |
|
|
|
Grzybowski A, Kanclerz P. Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1357. doi: 10.1007/s00417-018-3968-y. Epub 2018 Mar 30. PMID: 29602962; PMCID: PMC6006234. |
|
Excluded |
Comment |
Ronald A Cantrell, Jeffrey Ryuta Willis, Susanna S Park, Yifeng Chia, Mariam Abouhossein, Giulio Barteselli; Post-vitrectomy ocular hemorrhage among United States adults on oral antithrombotics. Invest. Ophthalmol. Vis. Sci. 2018;59(9):883. |
|
Excluded |
Abstract for a conference |
Shieh WS, Sridhar J, Hong BK, Maguire JI, Rahimy E, Shahlaee A, Ho AC, Hsu J, Regillo CD, Chiang A. Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications. Semin Ophthalmol. 2017;32(5):614-619. doi: 10.3109/08820538.2016.1139738. Epub 2016 Jul 1. PMID: 27367495. |
|
Excluded |
Small case series, 6 patients |
Mantopoulos D, Vavvas DG, Fine HF. Perioperative Risks of Antiplatelet and Anticoagulant Drugs in Vitreoretinal Procedures. Ophthalmic Surg Lasers Imaging Retina. 2017 Jan 1;48(1):4-8. doi: 10.3928/23258160-20161219-01. PMID: 28060388. |
|
Excluded |
Review |
Ajudani, R., Khosravi, M. H., Ramezani-Binabaj, M., Rezaee-Zavareh, M. S., & Alishiri, A. agha. (2017). Cessation or Continuation of Aspirin in Patients Undergoing 20-gauge Pars Plana Vitrectomy due to Diabetic Retinopathy. Galen Medical Journal, 6(2), 95-101. https://doi.org/10.31661/gmj.v6i2.763
|
|
|
|
Grand MG, Walia HS. HEMORRHAGIC RISK OF VITREORETINAL SURGERY IN PATIENTS MAINTAINED ON NOVEL ORAL ANTICOAGULANT THERAPY. Retina. 2016 Feb;36(2):299-304. doi: 10.1097/IAE.0000000000000783. PMID: 26447397. |
|
|
|
Brillat E, Rouberol F, Palombi K, Quesada JL, Bernheim D, Albaladejo P, Aptel F, Romanet JP, Chiquet C. A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1899-905. doi: 10.1007/s00417-014-2900-3. Epub 2015 Jan 11. PMID: 25576171. |
|
|
|
Witmer MT, Cohen SM. Oral anticoagulation and the risk of vitreous hemorrhage and retinal tears in eyes with acute posterior vitreous detachment. Retina. 2013 Mar;33(3):621-6. doi: 10.1097/IAE.0b013e3182671006. PMID: 23108264. |
|
|
|
Ryan, A., Saad, T., Kirwan, C., Keegan, D.J. and Acheson, R.W. (2013), Bleeding risks of vitreoretinal surgery. Clin Experiment Ophthalmol, 41: 387-395. https://doi-org.ezproxy.uio.no/10.1111/ceo.12017
|
|
|
|
Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C. Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery. Retina. 2012 Oct;32(9):1868-73. doi: 10.1097/IAE.0b013e31825097ae. PMID: 22495328. |
|
|
|
Malik AI, Foster RE, Correa ZM, Petersen MR, Miller DM, Riemann CD. Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents. Retina. 2012 May;32(5):905-11. doi: 10.1097/IAE.0b013e31822f55c4. PMID: 22298013. |
|
|
|
Mason JO 3rd, Gupta SR, Compton CJ, Frederick PA, Neimkin MG, Hill ML, Heersink MJ, Vail RS, White MF Jr, Feist RM, Thomley ML, Albert MA Jr. Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. Ophthalmology. 2011 Mar;118(3):543-7. doi: 10.1016/j.ophtha.2010.07.005. Epub 2010 Sep 29. PMID: 20884061. |
|
|
|
Fabinyi DC, O’Neill EC, Connell PP, Clark JB. Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents. Clin Exp Ophthalmol. 2011 Dec;39(9):878-84. doi: 10.1111/j.1442-9071.2011.02575.x. Epub 2011 Jun 14. PMID: 21631675. |
|
|
|
El-Sanhouri AA, Foster RE, Petersen MR, Hutchins RK, Miller DM, Evans TM, Trichopoulos N, Riemann CD. Retinal tears after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulants. Eye (Lond). 2011 Aug;25(8):1016-9. doi: 10.1038/eye.2011.106. Epub 2011 May 13. PMID: 21587275; PMCID: PMC3178220. |
|
|
|
Chandra A, Jazayeri F, Williamson TH. Warfarin in vitreoretinal surgery: a case controlled series. Br J Ophthalmol. 2011 Jul;95(7):976-8. doi: 10.1136/bjo.2010.187526. Epub 2010 Nov 11. PMID: 21071761. |
|
|
|
Brown JS, Mahmoud TH. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina. 2011 Nov;31(10):1983-7. doi: 10.1097/IAE.0b013e31821800cd. PMID: 21836531. |
|
|
|
Fu AD, McDonald HR, Williams DF, Cantrill HL, Ryan EH Jr, Johnson RN, Ai E, Jumper JM. Anticoagulation with warfarin in vitreoretinal surgery. Retina. 2007 Mar;27(3):290-5. doi: 10.1097/01.iae.0000243033.39301.10. PMID: 17460583. |
|
|
|
Dayani PN, Grand MG. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc. 2006;104:149-60. PMID: 17471335; PMCID: PMC1809899. |
|
|
|
Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand. 2003 Feb;81(1):38-40. doi: 10.1034/j.1600-0420.2003.00020.x. PMID: 12631017. |
|
|
|